Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The VERTIS trial, involving 8246 patients with T2DM, compared ertugliflozin 5 mg or 15 mg daily to placebo for 3.5 years
Key Benefits and Actions Soy-free liposomal format with supportive nutrient cofactors May help support the bodys healthy free-radical defenses May help support liver health May help support a healthy immune system Label Information Servings Per Container: 30 Serving Size: 1 teaspoon Amount Per Serving Calories - 10 Total Carbohydrates - 1 g - 1% Riboflavin (as riboflavin-5-phosphate) - 5 mg - 385% Choline (as phosphatidylcholine and choline bitartrate) - 64 mg - 12% Selenium (as selenomethionine) - 25 mcg - 45% Molybdenum (as molybdenum amino acid chelate) - 25 mcg - 56% Glutathione ( as S-acetyl-l-glutathione)(Emothion) - 100 mg PQQ (pyrroloquinoline quinone) - 2 mg Other Ingredients Water, natural flavors, sunflower lecithin with tocopherols, vegetable glycerin, organic acacia gum, potassium sorbate, Lipid Protect (oleic acid, CoQ10, tocotrienols with carotenoids, CMO (cetyl myristoleate)(from Kombo oil)(Pycnanthus angolensis)(nut), astaxanthin oil (algae) Suggested Use Shake lightly before each use
Purpose-built for physicians Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care Key takeaways: GLP-1 therapy can provide benefits beyond glycemic control for adults with type 2 diabetes
Panel member Elizabeth Rebello, a pharmacist and anaesthesiologist, told the committee she had voted no on BPC-157 "because of the lack of efficacy data" and "safety concerns", Reuters news agency reported
